跳至主要内容
临床试验/NCT02752698
NCT02752698Unknown不适用

Safety and Feasible Study of Domestic Surgical Robot That Had Been Authorized to Enter the Clinical Trial Stage

The Third Xiangya Hospital of Central South University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2015年1月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
200
试验地点
1
主要终点
intraoperative outcomes

研究概览

简要总结

Central South University in collaboration with Tianjin University developed the first domestically produced Chinese minimally invasive surgical (MIS) robot system which named "Micro Hand S" in 2013. Recently, as the domestic surgical robot research project's main section, this new MIS robot had been authorized to enter the clinical trial stage by the Ethics Committee of the Third Xiangya Hospital at Central South University.

详细描述

One surgeon perform these surgical trials using the robot "Micro Hand S". All of the patients were followed for 12 months, and pre- and postoperative changes in blood route test and hepatorenal function examination, surgery duration, hospital stay, total robotic setup time, total robotic operation time, intraoperative blood loss, total postoperative drainage amount, duration of bearing drainage tubes were recorded. In addition, the pre- and postoperative changes in the pathological and functional outcomes were measured.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of gastric tumor, colorectal tumor, acute cholecystitis and ileocecal tumor respectively
  • 18years<age<65years
  • male or female

排除标准

  • patients with a history of open abdominal surgery
  • unstable psychiatric illness
  • an inability or reluctance to cooperate during long-term follow-up
  • alcohol or drug addiction
  • or relatively high surgical risks, such as abnormal coagulation function or bad heart, lung, liver and kidney function, were excluded from this study

结局指标

主要结局

intraoperative outcomes

时间窗: up to 1 week after operation

surgical procedure/operative time/console time/blood loss/conversion

postoperative outcomes

时间窗: up to 1 month after operation

Time to first flatus/intake/hospital stay

complication

时间窗: within 30 days after surgery

type of complication/grade of complication

pathological outcomes

时间窗: up to 1 month after operation

resection margin/harvested lymph node/mesorectal grade

次要结局

  • recurrence(at least 12 months after operation)
  • functional outcomes(at least12 months after operation)
  • survival(at least 12 months yesra after operation)
  • change of blood and biochemiacl(within 1 month after operation)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验